Over 10,000 results
POS AM
OTLC
Oncotelic Therapeutics, Inc.
18 Apr 24
Prospectus update (post-effective amendment)
5:25pm
Research for Northwest Biotherapeutics, Inc., a cancer vaccine company focused on therapy for patients with glioblastoma multiforme and prostate cancer … molecule injectable drugs for the treatment of cancer. After the acquisition of Mateon Therapeutics, Inc through a reverse merger in 2019, we realigned
6-K
EX-99.1
006b647nqmcysvr
18 Apr 24
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
8:15am
F-1/A
4x9k2hr
18 Apr 24
Registration statement (foreign) (amended)
6:03am
S-3ASR
7y15sebbs ht73
17 Apr 24
Automatic shelf registration
5:24pm
424B4
7olfkpv56wctk5ziaw
17 Apr 24
Prospectus supplement with pricing info
4:15pm
424B5
1v9f 3ec6g
17 Apr 24
Prospectus supplement for primary offering
4:02pm
6-K
rmam0om
17 Apr 24
Current report (foreign)
9:30am
6-K
EX-99.1
ld32113
17 Apr 24
Current report (foreign)
9:30am
6-K
EX-99.1
h3iw494y
16 Apr 24
Current report (foreign)
6:30pm
424B3
a0h0jj 2v9asq
16 Apr 24
Prospectus supplement
5:16pm